The $13.1 billion acquisition of BMS by Pharmaceutical Headlines will continue the cardiovascular sector's success.

(2020/10/09) Merca East 2DR first-line treatment of HIV Phase 2b clinical efficacy comparable to the compound drug Delstrigo; Internet medical: hospital traffic can not be derived from the scale outside the hospital; (Click on the title, get the original text) "Pharmaceutical 1st time" Mercadon 2DR first-line treatment of HIV Phase 2b clinical efficacy comparable to the compound drug Delstrigo 8, Mercadon announced the evaluation of the new oral nucleoside reverse transcriptase transpase 96 weeks of data from the two-drug treatment (2DR) of the two-drug program (2DR) of bit inhibitors (NRTTI) islatravir and Pifeltro (Doravirine) for the treatment of stage 2b trials in adults with HIV-1.
results show that this 2DR is similar to the three-in-one drug Delstrigo (doravirine/3TC/TDF) in maintaining virological inhibition (HIV-1 RNA<50 copy/ml).
: None of the two treatment groups met the resistance test criteria.
.S. will continue its cardiovascular success with its $13.1 billion acquisition of BMS, which bought Celgene for $74 billion in November 2019.
deal has raised concerns in the global pharmaceutical industry and has become one of the most colorful in the history of pharmaceutical mergers and acquisitions.
less than a year after the shooting, BMS shot again.
October 5 (U.S. time), BMS announced that it would buy MyoKardia for $13.1 billion ($225 per share) in cash, setting a record for the size of a clinical-stage pharmaceutical company.
news, MyoKardia's shares soared 58.5 per cent.
: The acquisition of MyoKardia could bring three big benefits to BMS.
"Murafu Diary" Internet Medical: Hospital traffic can not be derived from the scale of out-of-hospital China's huge growth in medical services spending has been attracting investment imagination, but because the hospital also has a strong outpatient throughput capacity, hospitals at all levels in fact control the main flow and income inside and outside the hospital.
, the growth of medical services is mainly in the hands of large and medium-sized medical institutions, rather than single clinics or small hospitals, let alone online third-party medical service platforms.
: There is no possibility of another path outside the hospital.
Firestone Creation: The characteristics of the layout of typical CRO enterprises in China and the reasons behind them analyze the Cro Research Organization, which is short for Contract Research Organization, which is an organization or organization that provides specialized outsourcing services to pharmaceutical companies and other pharmaceutical research and development institutions in the form of contracts.
CRO industry originated in the United States in the 1970s, the late 1980s in Europe, the United States and Japan and other countries have been rapid development, the late 1990s to a certain industry scale, has become an indispensable part of the pharmaceutical research and development industry chain.
: The CRO industry is in the process of accelerating rapid expansion.
.